Fate Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 2.51 USD | 3,23 USD | 0,91 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5,411 USD | 5 | 1 | 6 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 116.559.186 | 7,11 | 1,52 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Fate Therapeutics Inc
Mitarbeiter 161
Handelsplatz NASDAQ
Ticker Symbol FATE
IPO Datum 2013-10-01
Adresse 12278 Scripps Summit Drive, San Diego, CA, United States, 92131
Webseite https://www.fatetherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Bahram Valamehr M.B.A., Ph.D. | President, CEO & Director |
| 2 | Mr. Kamal Adawi M.S., MBA | CFO & Treasurer |
| 3 | Ms. Cindy R. Tahl J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
| 4 | Ms. Jessica Francis | Senior Vice President of Human Resources & Operations |
| 5 | Dr. Martin Hosking | Head of Research |
| 6 | Dr. Tunde Babalola Ph.D. | Senior Vice President of Technical Operations & Quality |
| 7 | Mr. Ryan Douglas | Senior Director of Investor Relations & Business Development |
| 8 | Mr. Andrew Henry | Senior Vice President of Clinical Operations |
| 9 | Dr. Yu Cai J.D., Ph.D. | Head of Intellectual Property & Assistant General Counsel |
| 10 | Ms. Kate Duvall | Corporate Controller |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Redmile Group, LLC | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 7 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 8 | Johnson & Johnson | 0,00% | 0,00 Mio. USD |
| 9 | AQR Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 10 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 13 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 14 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 15 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 16 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 17 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 18 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 19 | Irenic Capital Management LP | 0,00% | 0,00 Mio. USD |
| 20 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |